Effects of digoxin on the anabolic response to clenbuterol.
The possible involvement of increased cation exchange in the anabolic response to the beta 2-selective adrenergic agonist clenbuterol was investigated using dietary admixtures of clenbuterol and the Na,K-adenosine triphosphatase (ATPase) inhibitor digoxin. In a rat feeding trial to assess the effects on body composition, it was found that the higher of two levels (5 and 30 mg/kg diet) of digoxin had an inhibitory effect on the repartitioning effects (ie, increased body weight and fat-free mass) of clenbuterol (2 mg/kg diet). In two further experiments using 30 and 60 mg digoxin/kg diet, it was found that the anabolic effects of clenbuterol on gastrocnemius muscle protein deposition were inhibited by digoxin, but the effects of clenbuterol on soleus muscle protein were more resistant to inhibition. Given the observed dose-dependent inhibition by digoxin of gastrocnemius muscle protein deposition in the three experiments, it was concluded that at least part of clenbuterol's anabolic actions on skeletal muscle may depend on increased Na,K-ATPase activity. However, different mechanisms or a different time course of Na,K-ATPase activation may occur in different muscle fiber types.
Cartaña
J
J
Department of Physiology, St George's Hospital Medical School, University of London, UK.
Stock
M J
MJ
D000704:Analysis of Variance; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D002976:Clenbuterol / Q000037:antagonists & inhibitors*; D004077:Digoxin / Q000494:pharmacology*; D005260:Female; D008297:Male; D009124:Muscle Proteins / Q000187:drug effects; D009132:Muscles / Q000187:drug effects / Q000201:enzymology; D051381:Rats; D017207:Rats, Sprague-Dawley; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects; D013997:Time Factors
D009124:Muscle Proteins; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase; D002976:Clenbuterol